Fundz

Visgenx reported raising $5.75 Million in an initial SEC Form D filing, from an offering of $3.5 Million

PRIVATEJun 14, 2023

Amount Raised

$5.75 Million

$5.75 Million sold, per SEC Form D (first sale Jun 2, 2023)

Round Type

Seed

San DiegoBiotechnologyHealth CareTherapeutics

Quick answer

Visgenx, Inc. raised $5.75 Million in a Seed round, dated June 2, 2023. Visgenx, Inc. is based in San Diego, California, United States.

How much did Visgenx, Inc. raise?
Visgenx, Inc. raised $5.75 Million in a Seed round on June 2, 2023.
What does Visgenx, Inc. do?
Visgenx, Inc. is a biotechnology company focused on developing gene-based therapeutics for degenerative retinal diseases.
Where is Visgenx, Inc. based and how big is it?
Visgenx, Inc. is based in San Diego, California, United States.
Who are the decision-makers at Visgenx, Inc?
Fundz holds 1 contact at Visgenx, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Visgenx, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Tenpoint Therapeutics raised $70M (Series A) on July 12, 2023.
  • Smartlens raised $6.1M (Series A) on July 11, 2023.
  • TolerogenixX raised $13M (Series A) on July 6, 2023.
  • MapLight Therapeutics raised $50M on July 5, 2023.
  • Actym Therapeutics raised $11M on June 28, 2023.
  • Foresee Pharmaceuticals raised $42M (Funding Round) on June 27, 2023.

Who to call at Visgenx, Inc., and when

A new round usually means Visgenx, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Visgenx, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Visgenx, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Visgenx, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Visgenx, Inc.

Location

3210 Merryfield Row

San Diego, California, United States

About

Visgenx, Inc. is a biotechnology company focused on developing gene-based therapeutics for degenerative retinal diseases. Visgenx' initial product is VGX-0111, a gene therapy candidate being developed for the treatment of dry Age-related Macular Degeneration (AMD). Close to 200 million people suffer from dry AMD globally; it is a leading cause of blindness. VGX-0111 is based on the ELOVL2 gene, which is required for the biosynthesis of lipids necessary for the function and survival of retinal cells. ELVOL2 expression declines with aging which may be an underlying pathology of dry AMD. VGX-0111 is intended to restore a normal level of ELOVL2 expression thereby slowing or halting the vision loss resulting from dry AMD. For more information on Visgenx, visit www.visgenx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Visgenx, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts8 people are listed at Visgenx, Inc.. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Visgenx, Inc.'s next move

See what Strategic adds

Visgenx, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.